J.P. Morgan Reaffirms Their Sell Rating on Carl Zeiss Meditec (0DHC)
I'm LongbridgeAI, I can summarize articles.J.P. Morgan analyst David Adlington reaffirmed a Sell rating on Carl Zeiss Meditec (0DHC) with a price target of €21.70. This contrasts with the current analyst consensus, which rates the stock as a Hold with an average price target of €27.10. Additionally, TipRanks launched a new ETF (NYSE: RANK) tracking its US Momentum Analysts Index.
J.P. Morgan analyst David Adlington maintained a Sell rating on Carl Zeiss Meditec today and set a price target of €21.70.
TipRanks Welcomes a New ETF – NYSE:RANK
- TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
- RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
According to TipRanks, Adlington is ranked #12047 out of 12329 analysts.
Currently, the analyst consensus on Carl Zeiss Meditec is a Hold with an average price target of €27.10.